MediWound's NexoBrid® Highlighted in 45 Posters and Presentations at the 19th European Burns Association Congress

YAVNE, Israel, Sept. 12, 2022 -- MediWound Ltd.  , a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration,... | September 12, 2022

Related Keywords

Italy ,United States ,Yavne ,Hamerkaz ,Israel ,American ,Boaz Gur Lavie ,Lior Rosenberg ,Monique Kosse ,Ofer Gonen ,Drug Administration ,Development Authority ,European Burns Association ,Nasdaq ,Mediwound Ltd ,Exchange Commission ,Us Biomedical Advanced Research ,European Union ,European Medicines Agency ,Globenewswire Inc ,Burns Association ,Chief Medical Officer ,Chief Executive Officer ,Burn Mass Casualties Incidents ,North American ,Advanced Research ,Quarterly Reports ,Mediwound Ltd Stock Exchange ,News ,Information ,Press Release ,022 ,Mediwound ,Bully ,Ntegrated ,Iopharmaceutical ,Company ,Ocused ,N ,Biotherapeutic ,Solutions ,Or ,Issue ,Repair ,Nd Mdwd Il0011316309 ,